Revenue + Forward P/E
Elevance Health Inc. (ELV) quarterly revenue and forward P/EForward P/E: 14.6x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$86.90B
Enterprise value
$102.72B
P/E ratio (TTM)
16.79x
P/S ratio (TTM)
0.41x
P/B ratio
1.83x
EV/Sales
0.51x
EV/EBITDA
12.83x
Dividend yield
1.82%
Income statement (TTM)
Revenue (TTM)
$199.12B
Gross profit (TTM)
$50.90B
Operating income (TTM)
$8.11B
EBITDA (TTM)
$9.66B
Net income (TTM)
$5.66B
Free cash flow (TTM)
$3.17B
Margins & returns
Gross margin
38.95%
Operating margin
3.51%
Profit margin
2.47%
Return on equity
11.24%
Return on assets
3.93%
Per-share metrics
EPS (TTM)
$22.78
Dividend yield
1.82%
Beta
0.68
Capital structure
Cash & equivalents
$9.49B
Total debt
$33.23B
Net debt
$23.74B
Shares outstanding
216.87M
Financial health
Current ratio
1.24
Debt / equity
0.76
Debt / assets
0.27
Interest coverage
5.79
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $629.78B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.08B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.18B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.26B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $86.90B | 16.79x | 0.41x | 12.83x | 1.82% |